-
Dynatrace Shares Drop As It Cuts FY23 Revenue Guidance; Clocks 30% Revenue Growth In Q2; Names New CFO
Wednesday, November 2, 2022 - 9:38am | 416Dynatrace, Inc (NYSE: DT) reported second-quarter FY23 revenue growth of 30% year-on-year to $279.3 million (CC), beating the consensus of $272.4 million. Total ARR increased 30% Y/Y to $1.06 billion (CC). Revenues from Subscription rose 29% Y/Y to $261.3 million (CC). Margins:...
-
Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday
Wednesday, September 28, 2022 - 5:10am | 2238Gainers Avenue Therapeutics, Inc. (NASDAQ: ATXI) shares climbed 106.3% to close at $9.15. Avenue Therapeutics recently received the official meeting minutes from the FDA regarding a meeting conducted for IV Tramadol in combination with other opioid analgesics to manage moderate-to-moderately...
-
This Analyst Boosts PT On PepsiCo? Plus UBS Sees $75 For Micron Technology
Tuesday, September 27, 2022 - 12:53pm | 302Deutsche Bank raised the price target on PepsiCo, Inc. (NASDAQ: PEP) from $179 to $181. Deutsche Bank analyst Steve Powers maintained a Hold rating on the stock. PepsiCo shares fell 1.2% to $166.47 on Tuesday. UBS cut the price target for Micron Technology, Inc. (NASDAQ: MU) from $80 to $75....
-
Why Bellerophon Therapeutics Shares Are Trading Higher By 24%, Here Are 44 Stocks Moving In Tuesday's Mid-Day Session
Tuesday, September 27, 2022 - 12:23pm | 1400Gainers Avenue Therapeutics, Inc. (NASDAQ: ATXI) shares surged 159.9% to $9.15. Avenue Therapeutics recently received the official meeting minutes from the FDA regarding a meeting conducted for IV Tramadol in combination with other opioid analgesics to manage moderate-to-moderately severe pain....
-
Equillium Buys Inflammatory Bowel Disease Player In All-Stock Deal
Wednesday, September 7, 2022 - 5:58am | 393Equillium Inc (NASDAQ: EQ) has agreed to acquire Metacrine Inc (NASDAQ: MTCR) in an all-stock transaction. The transaction is anticipated to add $33 million in cash to Equillium's balance sheet at closing, which is expected to extend the company's cash runway into...
-
Why CinCor Pharma Is Trading Higher By 63%, Here Are 79 Stocks Moving In Monday's Mid-Day Session
Monday, August 8, 2022 - 12:49pm | 2645Gainers Bonso Electronics International Inc. (NASDAQ: BNSO) shares jumped 132% to $11.12 after jumping around 46% on Friday. The company recently said it expects unaudited comprehensive loss of $1.6 million for fiscal year ended March 31, 2022. Magic Empire Global Limited (NASDAQ: MEGL) surged 110...
-
89 Biggest Movers From Friday
Tuesday, June 21, 2022 - 4:44am | 2704Gainers Revlon, Inc. (NYSE: REV) jumped 91.3% to close at $3.73 on Friday after the company filed for Chapter 11 bankruptcy. Grove Collaborative Holdings, Inc. (NYSE: GROV) rose 67.9% to close at $10.00. Grove Collaborative and Virgin Group Acquisition Corp. II announced the completion of their...
-
Approval Of Baricitinib For Patchy Baldness Validates Clinical Patch For This Small-Cap Stock
Tuesday, June 14, 2022 - 2:09pm | 428Olumiant (baricitinib), a Janus kinase (JAK) inhibitor, was developed by Incyte Corp (NASDAQ: INCY) and launched in collaboration with Eli Lilly And Co (NYSE: LLY), received FDA approval for hair loss disorder known as alopecia areata (AA). Olumiant was first approved for the...
-
10 Biggest Price Target Changes For Thursday
Thursday, May 19, 2022 - 8:26am | 418Telsey Advisory Group cut the price target for Bath & Body Works, Inc. (NYSE: BBWI) from $70 to $60. Bath & Body Works shares fell 6.9% to $40.00 in pre-market trading. Piper Sandler cut the price target on UWM Holdings Corporation (NYSE: UWMC) from $5 to $3. UWM Holdings shares fell 5...
-
Dynatrace Shares Gain On Q4 Beat; Discloses CFO Transition
Wednesday, May 18, 2022 - 8:48am | 247Dynatrace, Inc (NYSE: DT) reported fourth-quarter FY22 revenue growth of 31% year-on-year to $252.6 million (CC), beating the consensus of $246.6 million. Total ARR increased 29% Y/Y to $995.1 million. Revenues from Subscription rose 31% Y/Y to $239.9 million (CC). Margins:...
-
Here's How Rosenblatt Views Alteryx, Datadog, Dynatrace Ahead Of Earnings
Monday, May 2, 2022 - 3:54pm | 364Rosenblatt offers its insight on three tech stocks ahead of their earnings results in May. Alteryx, Inc (NYSE: AYX) will report Q1 results on May 3. Rosenblatt believes that the spending environment has continued to be positive in Q1 for enterprise Digital Transformation projects and low-code/...
-
Dynatrace Expands Partnership With Amazon Web Services
Thursday, March 31, 2022 - 1:41pm | 208Dynatrace Inc (NYSE: DT) has expanded its partnership with Amazon.Com Inc's (NASDAQ: AMZN) Amazon Web Services Inc (AWS). Under the partnership, Dynatrace will work with AWS to align on new product and solution development. The initiative will provide...
-
Equillium Adds Three Drugs To Its Pipeline Via Bioniz Acquisition
Wednesday, February 16, 2022 - 12:22pm | 328Equillium Inc (NASDAQ: EQ), with only one asset in its pipeline, is expanding its drug development efforts via the acquisition of Bioniz Therapeutics. The deal, worth approximately $330 million, gives the biotech access to three therapeutics. Equillium will buy Bioniz in an all...
-
54 Biggest Movers From Yesterday
Thursday, February 3, 2022 - 5:21am | 1882Gainers MDJM Ltd (NASDAQ: MDJH) shares surged 35.6% to close at $2.44 on Wednesday after gaining 10% on Tuesday. GWG Holdings, Inc. (NASDAQ: GWGH) gained 31.6% to settle at $4.50. Great Panther Mining Limited (NYSE: GPL) surged 31% to close at $0.2075. Great Panther recently reported full year...
-
Mid-Afternoon Market Update: Dow Surges Over 150 Points; PayPal Shares Slide On Earnings Miss
Wednesday, February 2, 2022 - 3:30pm | 874The Dow Jones extended gains later during the session, adding more than 150 points on Wednesday. Alphabet Inc. (NASDAQ: GOOGL) reported upbeat results for its fourth quarter and also announced a 20-for-1 stock split. Toward the end of trading Wednesday, the Dow traded up 0.45% to 35,563.95 while...